Interleukin-12 is indispensable for protective immunity against Leishmania major

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4378-4383

  Mattner, Frank ^a,c   Di Padova, Karin ^a   Alber, Gottfried ^a,b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 4; LYMPHOKINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMORAL IMMUNITY; IMMUNITY; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE;

EID: 0030784497     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4378-4383.1997     Document Type: Article

References (38)

1. Baniyash, M., and Z. Eshhar. 1984. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur. J. Immunol. 14:799-807.
2. Bretscher, P. A., O. Ogunremi, and J. N. Menon. 1997. Distinct immunological states in murine cutaneous leishmaniasis by immunising with ditferent amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful status. Behring Inst. Mitt. 98:153-159.
3. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major Science 257:539-542.
4. Cherwinsky, H. M., J. H. Schumachcr, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clones. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
5. Doherty, T. M., and R. Coffman. 1996. Leishmania major. effect of infectious dose of T cell subset development in BAI.B/c mice. Exp. Parasitol. 84:124-135.
6. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
7. Güler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984-990.
8. HayGlass, K. T., and B. P. Stefura. 1991. Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses. J. Exp. Med. 173:271-285.
9. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E,. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730-739.
10. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
11. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
12. Hsieh, C.-S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science 260:547-549.
13. Kolbe, L., C. Heusser, and E. Kölsch. 1991. Antigen dose-dependent regulation of B epsilon-memory cell expression. Int. Arch. Allergy Appl. Immunol. 95:202-208.
14. Kopf, M., F. Brombacher, G. Kienzle, K.-H. Widmann, K. Lefranc, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
15. - T cells which are NK1.1 Eur. J. Immunol. 25:3298-3307.
16. Locksley, R. M., and J. A. Louis. 1992. Immunology of leishmaniasis. Curr. Opin. Immunol. 4:413-418.
17. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471-481.
18. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559.
19. Menon, J. N., and P. A. Bretscher. 1996. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur. J. Immunol. 26:243-249.
20. Moll, H., S. Flohe, and M. Röllinghoff. 1995. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response Eur. J. Immunol. 25:693-699.
21. Mosmann, T. R., H. M. Cherwinsky, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of mouse helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
22. - T cell clones recognizing antigen(s) associated with live parasites. Eur. J. Immunol. 19:865-871.
23. Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987-990.
24. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333-336.
25. Okamura, H., H, Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, V. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91.
26. Prat, M., G. Gribaudo, P. Comoglio, G. Cavallo, and S. Lndolfo. 1984. Monoclonal antibodies against murine gamma interferon. Proc. Natl. Acad. Sci. USA 81:4515-4519.
27. Preston, P. M., and D. C. Dumonde. 1976. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin. Exp. Immunol. 23:126-138.
28. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
29. H2 subsets: doubt no more. Immunol. Today 12:256-257.
30. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibodies. J. Exp. Med. 171:115-127.
31. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
32. + T cells. Eur. J. Immunol. 24:343-347.
33. Scott, P. 1989. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp. Parasitol. 68:369-372.
34. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL. 4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
35. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schwab. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
36. Titus, R. G., R. Ceredig, J.-C Cerottini, and J. A. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J. Immunol. 135:2108-2114.
37. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555.
38. Zurawski, G., and J. E. De Vries. 1994. IL.13. an IL4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19-26.